Maricopa Integrated Health System
Phoenix, Arizona, 85008, United States
NCT Number: NCT00586729
This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Phoenix, Arizona, 85008, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Antimicrobial irrigant
Antimicrobial solution
Time frame: 14 days
Percentage area of graft viability at 14 days as determined by clinical assessment of revascularization, adherence of the graft to the wound bed and color
Time frame: 0 days, 3 days, 5 days and 14 days post-operation
Average hospital length of stay in days
Time frame: Volume used from admission to discharge
Average hospital irrigant cost per patient
Valleywise Health
Other
Pilot Study to Evaluate Effectiveness of Vashe™ Wound Therapy as an Antimicrobial Irrigant in Burn Wound Management
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07183943
Burns, Wounds and Injuries
Cairo, Egypt
View Trial DetailsNCT06116227
Burns, Wounds and Injuries
Cairo, Egypt
View Trial DetailsNCT07313735
Bandages, Behavior
Van, Turkey, Turkey (Türkiye)
View Trial DetailsNCT03692273
Burns, Cicatrix
Boston, Massachusetts, United States
View Trial Details